0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Drug Therapy
 161-180 of 605 Articles
Medical News & Perspectives | 
Bridget M. Kuehn, MSJ
JAMA. 2013;310(15):1547-1548. doi:10.1001/jama.2013.280076.

Original Investigation |  FREE
Björn Pasternak, MD, PhD; Henrik Svanström, MSc; Ditte Mølgaard-Nielsen, MSc; et al.
JAMA. 2013;310(15):1601-1611. doi:10.1001/jama.2013.278343.
Includes: Supplemental Content

News From the Centers for Disease Control and Prevention | 
JAMA. 2013;310(15):1553. doi:10.1001/jama.2013.278652.

News From the Centers for Disease Control and Prevention | 
JAMA. 2013;310(15):1552. doi:10.1001/jama.2013.278658.

Comment & Response | 
Toby Schonfeld, PhD; D. Micah Hester, PhD
JAMA. 2013;310(14):1504-1505. doi:10.1001/jama.2013.277296.

Comment & Response | 
Julia A. Glombiewski, PhD; Winfried Rief, PhD
JAMA. 2013;310(14):1505-1506. doi:10.1001/jama.2013.277299.

Comment & Response | 
Corrine I. Voils, PhD; Matthew L. Maciejewski, PhD
JAMA. 2013;310(14):1505. doi:10.1001/jama.2013.277302.

Comment & Response | 
Elizabeth Barker, MA, MSc; Crawford Hollingworth, BA
JAMA. 2013;310(14):1504. doi:10.1001/jama.2013.277308.

Comment & Response | 
Zachary A. Marcum, PharmD, MS; Mary Ann Sevick, ScD, RN; Steven M. Handler, MD, PhD
JAMA. 2013;310(14):1506-1507. doi:10.1001/jama.2013.277311.

Viewpoint | 
Brian P. O’Sullivan, MD; David M. Orenstein, MD, MA; Carlos E. Milla, MD
JAMA. 2013;310(13):1343-1344. doi:10.1001/jama.2013.278129.

From JAMA's Daily News Site | 
JAMA. 2013;310(12):1216. doi:10.1001/jama.2013.277708.

Comment & Response | 
John W. McEvoy, MBBCh, MRCPI; Roger S. Blumenthal, MD; Michael J. Blaha, MD, MPH
JAMA. 2013;310(11):1184-1185. doi:10.1001/jama.2013.276734.

Comment & Response | 
Paul von Hippel, MAS, PhD
JAMA. 2013;310(11):1185. doi:10.1001/jama.2013.276740.

Comment & Response | 
Edward H. Livingston, MD; Deborah T. Sugerman, MSW
JAMA. 2013;310(11):1185-1186. doi:10.1001/jama.2013.276743.

Viewpoint | 
Paul M Ridker, MD, MPH; Peter W. F. Wilson, MD
JAMA. 2013;310(11):1123-1124. doi:10.1001/jama.2013.276529.
Includes: Supplemental Content

Original Investigation |  FREE
Philippe Gabriel Steg , MD; Shamir R. Mehta, MD, MSc; Charles V. Pollack Jr, MD, MA; et al.
JAMA. 2013;310(11):1145-1155. doi:10.1001/jama.2013.277165.
Includes: Supplemental Content

Viewpoint | 
Bernard Lo, MD; Chelsea Ott, BA
JAMA. 2013;310(10):1019-1020. doi:10.1001/jama.2013.221227.

Viewpoint | 
Aaron S. Kesselheim, MD, JD, MPH; Michael D. Green, JD; Jerry Avorn, MD
JAMA. 2013;310(10):1023-1024. doi:10.1001/jama.2013.228349.

JAMA Clinical Challenge | 
Hsien-Yi Chiu, MD; Hsien-Ching Chiu, MD
JAMA. 2013;310(10):1068-1069. doi:10.1001/jama.2013.276214.

Comment & Response | 
Jashin J. Wu, MD
JAMA. 2013;310(10):1075-1076. doi:10.1001/jama.2013.276749.

Sign in

Purchase Options

• Subscribe to the journal

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Psychiatry
Original Investigation  | 
Efficacy and Safety of the 3-Month Formulation of Paliperidone Palmitate vs Placebo for Relapse Prevention of Schizophrenia:  A Randomized Clinical Trial
Joris Berwaerts, MD; Yanning Liu, MS; Srihari Gopal, MD, MHS; et al.
JAMA Oncology
Editorial  | 
Thiopurines for the Treatment of Acute Lymphoblastic Leukemia in Children:  What’s Old Is New
Franklin O. Smith, MD; Maureen M. O’Brien, MD, MS
JAMA Oncology
Original Investigation  | 
Systemic Exposure to Thiopurines and Risk of Relapse in Children With Acute Lymphoblastic Leukemia:  A Children’s Oncology Group Study
Smita Bhatia, MD, MPH; Wendy Landier, PhD, RN; Lindsey Hageman, MPH; et al.
JAMA Oncology
Viewpoint  | 
The Cost and Value of Anti–Epidermal Growth Factor Receptor Therapies:  Let's Not Be Rash
Leonard B. Saltz, MD